In Vitro Antimicrobial Activity of Gatifloxacin Against N. gonorrhoeae and H. influenzae Douglas J. BiedenbachR. N. JonesG. V. Doern Poster Presentations 01 December 2012 Pages: 178 - 179
Antimicrobial Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia spp. Douglas J. BiedenbachR. N. JonesM. A. T. Croco Poster Presentations 01 December 2012 Pages: 180 - 181
Activity of Moxifloxacin Against Klebstella pneumoniae A. Dalhoff Poster Presentations 01 December 2012 Pages: 182 - 183
Serum Bactericidal Activity of Moxifloxacin A. DalhoffH. StassS. Obertegger Poster Presentations 01 December 2012 Pages: 184 - 185
Current Activity of Ciprofloxacin Against Gram-Negative Bacilli in the United States C. ThornsberryM. K. MarsilioDaniel F. Sahm Poster Presentations 01 December 2012 Pages: 186 - 187
Comparison of In Vitro Activity of Trovafloxacin, Ciprofloxacin and Ceftazidime on Clinical Isolates Betigül ÖngenArif KaygusuzKurtulus Töreci Poster Presentations 01 December 2012 Pages: 188 - 189
Comparative Activity of 7 Quinolones Against Non-Glucose Fermenting Gram-Negative Bacilli Isolated from Cancer Patients Maya BalakrishnanHeidi MagoKenneth V. I. Rolston Poster Presentations 01 December 2012 Pages: 190 - 192
Susceptibility of Anaerobic Gram-Negative Rods to Trovafloxacin Mirta LitterioL. CastelloH. Bianchini Poster Presentations 01 December 2012 Pages: 193 - 194
Comparative In Vitro Activity of Trovafloxacin Against Gram-Positive and Gram-Negative Clinical Isolates from Argentina Adriana SucariD. StepanikH. López Poster Presentations 01 December 2012 Pages: 195 - 199
In Vitro Activity of Trovafloxacin, Ciprofloxacin, Azithromycin, Roxithromycin and Clarithromycin Against 355 Clinical Isolates with Different Resistance Patterns José María CasellasG. ToméS. Ivanovic Poster Presentations 01 December 2012 Pages: 200 - 202
Trovafloxacin: In Vitro Activity and Comparison with Other Antibacterial Agents A. RossiM. TokumotoWHONET-Argentina Collaborative Group Poster Presentations 01 December 2012 Pages: 203 - 206
Activity of Trovafloxacin Against P. aeruginosa, Methicillin-Resistant S. aureus and Pneumococci Linda M. KellyMichael R. JacobsPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 207 - 208
Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients to Ciprofloxacin A. BauernfeindR. JungwirthF. Ratjen Poster Presentations 01 December 2012 Pages: 209 - 210
Susceptibility of Pseudomonas aeruginosa to Levofloxacin and Trovafloxacin Based on MICs for Ciprofloxacin and Ofloxacin Ken B. Waites Poster Presentations 01 December 2012 Pages: 211 - 213
Susceptibility of Stenotrophomonas maltophilia to Moxifloxacin, Trovafloxacin, Ofloxacin and Ciprofloxacin H. Bradford HawleyHari M. PolenakovikSusan S. Mueller Poster Presentations 01 December 2012 Pages: 214 - 216
Clinafloxacin Antibacterial Activity Lois M. EdnieMichael R. JacobsPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 217 - 221
Single Dose Pharmacokinetics of the R- and S-Enantiomers of Gatifloxacin in Volunteers H.-J. StahlbergK. GoehlerA. Mignot Poster Presentations 01 December 2012 Pages: 222 - 224
Basic Pharmacokinetics of Moxifloxacin H. StassD. Kubitza Poster Presentations 01 December 2012 Pages: 225 - 226
Absorption and Bioavailability of Moxifloxacin H. Stass Poster Presentations 01 December 2012 Pages: 227 - 228
Distribution and Tissue Penetration of Moxifloxacin H. Stass Poster Presentations 01 December 2012 Pages: 229 - 230
Metabolism and Excretion of Moxifloxacin H. Stass Poster Presentations 01 December 2012 Pages: 231 - 232
Pharmacokinetics of Moxifloxacin in Special Populations H. StassJ. Lettieri Poster Presentations 01 December 2012 Pages: 233 - 234
Interaction Profile of Moxifloxacin H. StassD. Kubitza Poster Presentations 01 December 2012 Pages: 235 - 236
Advances in Bioanalytical Methodology Used to Characterise Clinical Pharmacokinetics of Moxifloxacin J.-G. MöllerH. StassW. Mück Poster Presentations 01 December 2012 Pages: 237 - 238
Determination of Moxifloxacin by HPLC and Bioassay A. DalhoffH. Stass Poster Presentations 01 December 2012 Pages: 239 - 241
Impact of Neutropenia on Tissue Penetration of Moxifloxacin and Sparfloxacin in Infected Mice R. GarraffoC. RoptinA. Boudjadja Poster Presentations 01 December 2012 Pages: 242 - 245
Effect of Age on Clinafloxacin Pharmacokinetics in Healthy Volunteers E. J. RandinitisR. AbelA. B. Vassos Poster Presentations 01 December 2012 Pages: 246 - 247
Effect of Clinafloxacin on the Pharmacokinetics of Theophylline and Caffeine E. J. RandinitisJ. R. KoupA. B. Vassos Poster Presentations 01 December 2012 Pages: 248 - 249
Clinafloxacin Pharmacokinetics in Renal Patients J. RandinitisJ. R. KoupA. J. Sedman Poster Presentations 01 December 2012 Pages: 250 - 251
Pharmacokinetics of Oral and Intravenous Clinafloxacin E. J. RandinitisJ. BrodfuehrerA. B. Vassos Poster Presentations 01 December 2012 Pages: 252 - 253
Drug Interaction Studies with Clinafloxacin and Probenecid, Cimetidine, Phenytoin and Warfarin E. J. RandinitisJ. R. KoupA. J. Sedman Poster Presentations 01 December 2012 Pages: 254 - 255
Effects of Food and Antacid on the Pharmacokinetics of Clinafloxacin C. AlveyE. J. RandinitisA. B. Vassos Poster Presentations 01 December 2012 Pages: 256 - 257
In Vitro Pharmacodynamic and Pharmacokinetic Aspects of THP-1 Human Monocyte Uptake, Distribution and Efflux of 14C-Grepafloxacin under Different Conditions M. A. DietrichJ. D. ButtsI. H. Hall Poster Presentations 01 December 2012 Pages: 258 - 259
Clinafloxacin in Serious Infections Caused by Multiply Resistant Pathogens Kenneth J. TackIrene EisemanMarcus Zervos Poster Presentations 01 December 2012 Pages: 260 - 262
Ciprofloxacin in the Treatment of Nosocomial Meningitis in Neonates and Infants J. FilkaJ. UherV. Krcméry Jr Poster Presentations 01 December 2012 Pages: 263 - 265
Bacteraemia and Fungaemia During Ofloxacin Prophylaxis in Cancer Patients V. Krcméry JrJ. TruplF. Mateicka Poster Presentations 01 December 2012 Pages: 266 - 268
Pharmacodynamics of Trovafloxacin vs Ceftriaxone in Streptococcus pneumoniae Philip D. ListerChristine C. Sanders Poster Presentations 01 December 2012 Pages: 269 - 270
Use of Intravenous Ciprofloxacin in a Canadian Medical Centre J. A. KarlowskyA. S. GinG. G. Zhanel Poster Presentations 01 December 2012 Pages: 271 - 272
A Critical Pathway for the Treatment of Community-Acquired Pneumonia Thomas J. MarrieCatherine Y. LaucapitaL Study Investigators Poster Presentations 01 December 2012 Pages: 273 - 275
The Microbiological Eradication Rate of First-Line Antibiotic Treatment is a Key Cost Driver in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis L. F. LaceyT. VolmerA. M. Harris Poster Presentations 01 December 2012 Pages: 276 - 277
The Clinical Failure Rate of First-Line Antibiotic Treatment is the Key Cost Driver in Community-Acquired Lower Respiratory Tract Infections H. J. J. van BarlingenT. VolmerL. F. Lacey Poster Presentations 01 December 2012 Pages: 278 - 279
Efficacy of Gatifloxacin in Pneumococcal Respiratory Infection Rinzo SoejimaAtsushi Saito Poster Presentations 01 December 2012 Pages: 280 - 281
Ofloxacin Once Daily Versus Twice Daily in Community-Acquired Pneumonia V. Kronéry Jrthe Slovak GP Study Group Poster Presentations 01 December 2012 Pages: 282 - 283
Oral Trovafloxacin Versus Intravenous Cefoxitin in Elective Hysterectomy D. R. Lukethe Trovafloxacin Surgical Prophylaxis Study Group Poster Presentations 01 December 2012 Pages: 284 - 285
Alatrofloxacin Versus Cefotetan in Prophylaxis of Colorectal Surgery D. R. Lukethe Trovafloxacin Surgical Prophylaxis Study Group Poster Presentations 01 December 2012 Pages: 286 - 287
Comparison of the Efficacy and Safety of Once-Daily Oral Trovafloxacin and 3-Times-Daily Amoxicillin/Clavulanic Acid for the Treatment of Complicated Skin and Soft-Tissue Infections R. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 288 - 290
Once-Daily Oral Trovafloxacin in the Treatment of Diabetic Foot Infections R. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 291 - 292
Trovafloxacin Once Daily vs Flucloxacillin Four Times Daily in the Treatment of Uncomplicated Skin and Skin-Structure Infections R. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 293 - 294
Comparison of Intravenous to Oral Trovafloxacin vs Intravenous Imipenem/Cilastatin to Oral Amoxicillin/Clavulanic Acid in Complicated Intra-Abdominal Infections D. R. Lukethe Trovafloxacin Intra-Abdominal Infection Study Group Poster Presentations 01 December 2012 Pages: 295 - 297
Failure of Alatrofloxacin in Patients with Deep Surgical Infection V. GandhiK. PatelE. M. Sordillo Poster Presentations 01 December 2012 Pages: 298 - 300
